55 results
Page 2 of 3
8-K
EX-1.1
161bkq lw
20 Nov 19
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-99.1
ozlb6peb2k v08atl
1 May 19
Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab
7:45am
10-K
EX-10.8
8vj3lpkmo521m
17 Mar 17
Annual report
12:00am
10-K
abs 77lt9fz
17 Mar 17
Annual report
12:00am
10-Q
wlh2s7stj9 jrylqz
14 Nov 16
Quarterly report
12:00am
10-12G/A
208psxw msljt8m8e
19 Aug 16
Registration of securities (amended)
12:00am
10-12G/A
EX-10.19
yqrfz5z7kumu2rovli4
19 Aug 16
Registration of securities (amended)
12:00am